BOLT vs OKE · rev $7.7M vs P/E 15, rev $21.70B
Bolt Biotherapeutics (BOLT) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
BOLT currently screens at market cap $11.3M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the BOLT and OKE stock pages for the full models.
Not investment advice.